Clinical Trial Update: Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring a novel therapeutic target to reduce dementia risk in Parkinson disease; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Parkinson Disease

Snippet

Sponsor: The University of Queensland | Conditions: Parkinson Disease, Mild Cognitive Impairment | Phase 2 | Status: RECRUITING